financetom
Business
financetom
/
Business
/
Market Chatter: Nvidia to Defend Appeal in Securities Fraud Case Before US Supreme Court
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Nvidia to Defend Appeal in Securities Fraud Case Before US Supreme Court
Nov 13, 2024 11:16 AM

07:35 AM EST, 11/13/2024 (MT Newswires) -- Nvidia ( NVDA ) is expected to present Wednesday its arguments at the US Supreme Court in its appeal of a court decision allowing a securities fraud lawsuit, Reuters reported.

The 2018 class action lawsuit accuses the company of making statements in 2017 and 2018 that falsely downplayed how much of its revenue growth was pumped by purchases of cryptocurrencies, according to the report.

The semiconductor giant did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 148.63, Change: +0.34, Percent Change: +0.23

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BW LPG Nearing Completion of 12-Vessel Purchase Agreement with Swedish Shippers
BW LPG Nearing Completion of 12-Vessel Purchase Agreement with Swedish Shippers
Dec 18, 2024
10:59 AM EST, 12/18/2024 (MT Newswires) -- BW LPG ( BWLP ) said Wednesday that Avance Gas Holdings now owns nearly 11% of its outstanding stock after issuing about 1.4 million common shares after taking delivery of the BW Monsoon liquefied petroleum gas vessel from Avance this week. Overall, BW LPS has received 11 of the 12 Very Large Gas...
KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says
KalVista Pharmaceuticals' Sebetralstat Poised to Disrupt Acute HAE Market With Oral Advantage, BofA Says
Dec 18, 2024
10:54 AM EST, 12/18/2024 (MT Newswires) -- KalVista Pharmaceuticals' ( KALV ) drug candidate sebetralstat is a promising, on-demand oral treatment for hereditary angioedema that demonstrated efficacy comparable to approved injectables with the added convenience of oral dosing in a phase 3 study, BofA Securities said in a note on Wednesday. The firm assigned a 75% likelihood of success for...
What's Going On With Polyrizon Shares Wednesday?
What's Going On With Polyrizon Shares Wednesday?
Dec 18, 2024
Polyrizon Ltd. ( PLRZ ) shares are moving higher after the company announced it secured a manufacturing agreement with Eurofins CDMO Amatsiaquitaine. The Details: Under the agreement, Eurofins will supply Polyrizon ( PLRZ ) with Clinical Trial Material (CTM) for its PL-14 allergy blocker trial. The clinical trial, expected to commence in 2025, will evaluate the safety and efficacy of...
Market Chatter: Apollo in Talks to Buy GFL's Environmental Services Unit
Market Chatter: Apollo in Talks to Buy GFL's Environmental Services Unit
Dec 18, 2024
10:54 AM EST, 12/18/2024 (MT Newswires) -- Apollo Global Management ( APO ) is in talks to buy GFL Environmental's ( GFL ) environmental services division for about $8 billion, The Globe and Mail reported Wednesday, citing two sources familiar with the negotiations. The deal is expected to be announced in early January, according to the report. Apollo and GFL...
Copyright 2023-2026 - www.financetom.com All Rights Reserved